Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 798 results for "barda"

Cerus Corporation is Surging Today. Here's Why.
Motley Fool

Cerus Announces Agreement with BARDA for Potential Funding of ...

Cerus Announces Agreement with BARDA for Potential Funding ofup to approximately $180 million to Advance its INTERCEPT Red Blood Cell Program CONCORD, CA --( )-- June 19, 2016 -- Cerus Corporation (NASDAQ: CERS), a biomedical products company ... PressReleasePoint, 5 days ago
[x]  

33 images for barda

Jerusalem Post, 1 week ago
National News Agency Lebanon, 4 days ago
Jerusalem Post, 1 week ago
Arts Journal, 3 weeks ago
netdna-cdn.com, 3 weeks ago
Yahoo! Singapore, 1 month ago
BioSpace, 1 month ago
Nasdaq, 1 month ago
RTTNews.com, 1 month ago
Arizona State University, 1 month ago

Emergent receives task order from BARDA to develop Zika vaccine

(MarketLine via COMTEX News Network) -- Emergent BioSolutions Inc. has announced that its Center for Innovation in Advanced Development and Manufacturing, or CIADM, has received a task order from the Biomedical Advanced R&D Authority, or BARDA, ...
 PredictWallStreet2 weeks ago Emergent receives BARDA Order valued up to $21.9m to develop and manufacture Zika vaccine  CBRNe World3 weeks ago Emergent BioSolutions Receives BARDA Task Order Valued at Up to $21.9M to Develop and Manufacture a Zika Vaccine  American Pharmaceutical Outsourcing3 weeks ago Emergent Bio nabs BARDA contract to fund development and manufacture Zika vaccine  Seeking Alpha3 weeks ago
[x]  
MassDevice

Avita taps IMS for BARDA economics study of ReCell

Avita Medical (ASX: AVH ) said today it tapped health economics group IMS Health to join in an study of its ReCell regenerative medical device to evaluate its economic benefits when used at U.S. burn centers. The ReCell device is designed to use ...
 MassDevice3 weeks ago Avita Medical Receives Added BARDA Funds for Burn Treatment Product Development; Adam Kelliher Comments  ExecutiveBiz3 weeks ago Avita Medical Awarded US796m in BARDA Extension Deal  Asian Hospital & Healthcare Management3 weeks ago Avita snags $8M from BARDA to aid in PMA filing for ReCell  FierceMedicalDevices3 weeks ago
[x]  
WorldNetDaily

Terumo BCT receives $17.4 mn BARDA funding to initiate clinical trial using Mirasol PRT system in US

Terumo BCT, a global medical device manufacturing company, has announced that it has been awarded $17.4 million in initial funding from the Biomedical Advanced Research and Development Authority (BARDA) to initiate a clinical trial using the Mirasol ...
 PharmaBiz1 month ago BARDA Issues Platelet Treatment Tech Trial Grant to Terumo BCT  ExecutiveBiz1 month ago Terumo BCT wins $17.4m funding contract from BARDA  Medical Devices Business Review1 month ago Terumo BCT Announces a $17.4 Million Funding Contract from the Biomedical Advanced Research and Development Authority (BARDA)  WorldNetDaily1 month ago
[x]  

United States : Cerus signs $180.5M agreement with U.S. BARDA [TendersInfo (India)]

Cerus has signed a $180.5 million agreement with the U.S. Biomedical Advanced Research and Development Authority (BARDA) aiming at supporting the companys clinical development program for pathogen reduction of red blood cell (RBC) components. ...
 Pharmacy Choice1 month ago Cerus signs agreement with BARDA to advance its INTERCEPT red blood cell program  Medical Devices Business Review1 month ago Cerus and BARDA to support clinical development of Intercept blood system  Medical Device Network1 month ago Cerus inks 5-year contract with BARDA potentially worth $180.5M to develop INTERECEPT for pathogen reduction of red blood cell components  Seeking Alpha1 month ago
[x]  

5 Companies Achieve 5a-Week Highs

- By yifan900According to , these guru stocks have reached their 52-week highs. C.R. BardA reaches the 52-week high of $220.62 C.R. Bard Inc. A (BCR) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, ...
 Yahoo! Finance1 month ago

BRIEF-Achaogen awarded $20 mln contract option by BARDA for developing plazomicin

June 2 Achaogen Awarded $20 Million Contract Option By Barda To Support Development Of Plazomicin For Multi * Achaogen inc says entered into an agreement to sell shares of its common stock and warrants to purchase shares for gross proceeds of ...
 Reuters UK1 month ago Achaogen Awarded $20 Million Contract Option by BARDA to Support Development of Plazomicin for Multi-Drug Resistant Gram-Negative Infections  Yahoo! 7 Finance1 month ago ACHAOGEN : Awarded $20 Million Contract Option by BARDA to Support Development of Plazomicin for Multi-Drug Resistant Gram-Negative Infections  4 Traders1 month ago Achaogen's Plazomicin Highlighted in Multiple Presentations at ASM Microbe 2016 Outlining Bactericidal Activity Against MDR Pathogens  4 Traders1 month ago
[x]  
Nasdaq

CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017

In addition to providing funding to advance its INTERCEPT red blood cell program, the subsequent options of the contract if exercised by BARDA would fund activities related to broader implementation in areas of Zika virus risk, clinical and ...
 Nasdaq1 month ago CERUS : CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017  4 Traders1 month ago
[x]  

Atox Bio Awarded Next Milestone-based Option by BARDA to Support Development of AB103 for Necrotizing Soft Tissue Infections

NESS ZIONA, Israel , June 15, 2016 /PRNewswire/ -- Atox Bio , a clinical stage company developing novel immunemodulators for critically ill patients with severe infections, today announced that it has been awarded the next option on a ...
 International Business Times1 month ago Atox Bio Awarded Next Milestonebased Option by BARDA to Support Development of AB103 for Necrotizing Soft Tissue Infections  Pharma Focus Asia1 month ago
[x]  
PharmaVOICE

Novavax Announces New Seasonal Combination Respiratory Vaccine Program

Seasonal influenza nanoparticle approach replaces VLP program HHS BARDA contract will complete its term as scheduled in September 2016 Nanoparticle design builds on advances achieved with RSV F Vaccine Animal immunogenicity and efficacy data ...
 PharmaVOICE1 month ago Novavax, Inc: Piper Jaffray Views VLP Flu Vaccine Program as a Positive  Bidness Etc1 month ago NOVAVAX : Announces New Seasonal Combination Respiratory Vaccine Program-  4 Traders1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - barda
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less